Authors: Gobbi, PG Zinzani, PL Broglia, C Comelli, M Magagnoli, M Federico, M Merli, F Iannitto, E Tura, S Ascari, E

Citation: Pg. Gobbi et al., Comparison of prognostic models in patients with advanced Hodgkin disease - Promising results from integration of the best three systems, CANCER, 91(8), 2001, pp. 1467-1478

Authors: Quintini, G Barbera, V Iannitto, E Mariani, G

Citation: G. Quintini et al., Potential strategies for the treatment of plasma exchange-resistant thrombotic thrombocytopenic purpura, BR J HAEM, 113(2), 2001, pp. 560-561

Authors: Turri, D Iannitto, E Caracciolo, C Mariani, G

Citation: D. Turri et al., Oral anticoagulants and cyclosporin A, HAEMATOLOG, 85(8), 2000, pp. 893-894

Authors: Gobbi, PG Broglia, C Berte, R Petrilli, MP Molica, S Angrilli, F Iannitto, E Ghirardelli, ML Di Renzo, N Cavanna, L Ascari, E

Citation: Pg. Gobbi et al., Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease, HAEMATOLOG, 85(7), 2000, pp. 722-728

Authors: Carroccio, A Fabiani, E Iannitto, E Giannitrapani, L Gravina, F Montalto, G Catassi, C

Citation: A. Carroccio et al., Tissue transglutaminase autoantibodies in patients with non-Hodgkin's lymphoma - Case reports, DIGESTION, 62(4), 2000, pp. 271-275

Authors: Musso, M Porretto, F Crescimanno, A Bondi, F Polizzi, V Scalone, R Iannitto, E Mariani, G

Citation: M. Musso et al., Successful treatment of resistant thrombotic thrombocytopenic purpura/hemolytic uremic syndrome with autologous peripheral blood stem and progenitor (CD34(+)) cell transplantation, BONE MAR TR, 24(2), 1999, pp. 207-209